| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |